title: Predicting the solubility of the anti-cancer agent docetaxel in small molecule excipients using computational methods.
abstract: OBJECTIVE
  To develop an in silico model that provides an accurate prediction of the relative solubility of the lipophilic anticancer agent docetaxel in various excipients.
  
  
  METHODS
  The in silico solubility of docetaxel in the excipients was estimated by means of the solubility (delta) and Flory-Huggins interaction (chi (FH)) parameters. The delta values of docetaxel and excipients were calculated using semi-empirical methods and molecular dynamics (MD) simulations. Cerius(2) software and COMPASS force-field were employed for the MD simulations. The chi (FH) values for the binary mixtures of docetaxel and excipient were also estimated by MD simulations.
  
  
  RESULTS
  The values obtained from the MD simulations for the solubility of docetaxel in the various excipients were in good agreement with the experimentally determined values. The simulated values for solubility of docetaxel in tributyrin, tricaproin and vitamin E were within 2 to 6% of the experimental values. MD simulations predicted docetaxel to be insoluble in beta-caryophyllene and this result correlated well with experimental studies.
  
  
  CONCLUSIONS
  The MD model proved to be a reliable tool for selecting suitable excipients for the solubilization of docetaxel.
authors: Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
authors: Loan
authors: L
authors: Huynh
authors: Justin
authors: J
authors: Grant
authors: Jean-Christophe
authors: JC
authors: Leroux
authors: Pascal
authors: P
authors: Delmas
authors: Christine
authors: C
authors: Allen
mesh_terms: D000465:Algorithms; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D003198:Computer Simulation; D000077143:Docetaxel; D005079:Excipients / Q000737:chemistry*; D006860:Hydrogen Bonding; D008055:Lipids / Q000737:chemistry; D008958:Models, Molecular; D012995:Solubility; D043823:Taxoids / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D005079:Excipients; D008055:Lipids; D043823:Taxoids; D000077143:Docetaxel
references: Adv Drug Deliv Rev. 2002 Nov 1;54 Suppl 1:S77-98
references: 12460717
references: Int J Cancer. 2001 Mar 15;91(6):840-5
references: 11275989
references: Pharm Res. 2006 Apr;23(4):752-8
references: 16550475
references: Chem Pharm Bull (Tokyo). 2005 Aug;53(8):893-8
references: 16079515
references: J Pharm Sci. 1999 Nov;88(11):1182-90
references: 10564068
references: J Chromatogr A. 2005 Jan 28;1064(1):85-95
references: 15729823
references: Mol Cancer Ther. 2003 Mar;2(3):227-33
references: 12657717
references: J Control Release. 2003 Sep 19;92(1-2):19-26
references: 14499182
references: Pharm Res. 2004 Feb;21(2):201-30
references: 15032302
references: J Colloid Interface Sci. 2004 Jun 1;274(1):55-68
references: 15120278
references: J Pharm Sci. 1997 Dec;86(12):1458-63
references: 9423162
references: J Control Release. 2002 Dec 13;85(1-3):51-9
references: 12480311
references: J Control Release. 1999 Apr 19;58(3):271-8
references: 10099152
references: Drug Discov Today. 2006 Nov;11(21-22):1012-8
references: 17055411
references: Nat Mater. 2004 Sep;3(9):638-44
references: 15300242
references: Int J Pharm. 2003 Jun 4;258(1-2):193-201
references: 12753765
references: J Clin Oncol. 1995 Oct;13(10):2643-55
references: 7595719
references: J Control Release. 2005 Feb 2;102(2):415-25
references: 15653161
references: N Engl J Med. 1995 Apr 13;332(15):1004-14
references: 7885406
references: J Chromatogr A. 2005 May 6;1073(1-2):347-53
references: 15909540
references: J Control Release. 1998 Jan 2;50(1-3):135-43
references: 9685880
references: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references: 11259830
references: Mol Pharmacol. 2006 Dec;70(6):1935-45
references: 16998007
references: Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6920-4
references: 7624344
references: J Med Chem. 1995 Sep 15;38(19):3821-8
references: 7562913